Pay in 4 interest-free payments of $27.50 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Clomethiazole (30 μM) at low concentration also potentiates the action of GABA in both cell types
Smiles: OC1=CC=CC(OCC2CC2)=C1C1=CC([C@@H]2CNCCC2)=C2COC(=O)NC2=N1
PNU-120596 increases agonists (choline and ACh)-evoked currents mediated by wild-type receptors and also demonstrates a pronounced prolongation of the evoked response in the continued presence of agonist in Xenopus oocytes
Smiles: [2H]C1=C2C(C(=O)N(C3CCC(=O)NC3=O)C2=O)=C([2H])C([2H])=C1[2H]
a novel G(2) checkpoint abrogator
Anlotinib HCl Catalog No.:M33595-10 Clomethiazole (30 μM) at lowAnlotinib, also known as AL3818 and Catequentinib, is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth. Product information CAS Number: 1360460 82 7 Molecular Weight: 480. 36 Formula: